3653 results for «358»
3653 results
EuroPCR 2023 Grande Finale
19 May 2023 – From EuroPCR 2023
EuroPCR 2023 comes to a close with a selection of cases demonstrating the major human impact of interventions, not only on patients' clinical outcomes, but also on their families, and even on society itself. The idea is to follow the theme of this year's edition, which...
How CTO techniques can help you in your everyday practice?
17 May 2023 – From EuroPCR 2023
Consult this session if you want to improve your skills in coronary intervention problem solving, to learn how techniques used in CTO PCI can solve problems in non-CTO PCI, and to discuss how to overcome PCI barriers and complications.
TAVI for bicuspid anatomy: beyond type I LR
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand the challenges of bicuspid aortic stenosis patients, type 0 in particular, to review contemporary sizing methods in bicuspid aortic stenosis, and to tailor the implant technique to individual patient.
Managing high-bleeding risk in case examples
18 May 2023 – From EuroPCR 2023
In these slides, discover techniques to assess bleeding and thrombotic risk in PCI patients, explore antithrombotic options, and implement strategies for risk minimisation.
Current trends in the invasive treatment of pulmonary embolism
18 May 2023 – From EuroPCR 2023
Embark on an exploration of the current trends in the invasive treatment of pulmonary embolism. Grasp the intricacies of establishing a catheter intervention service, navigate patient selection for advanced devices like catheter-directed thrombolysis and mechanical thrombectomy, and stay ahead by reviewing the latest clinical trials in...
TAVI troubles - The role of Nurses and Allied Professionals
18 May 2023 – From EuroPCR 2023
In these slides, gain insights into potential TAVI issues, learn to anticipate and manage complications, and explore the pivotal role of NAP\'s.
Calcified distal left main stenosis - LIVE case
18 May 2023 – From EuroPCR 2023
Watch the case of a 62-year-old non-diabetic male patient with history of stroke and peripheral artery disease, normal ECG and left ventricular function, referred for CT scan and angiography. He presented with calcified distal LM stenosis and calcified proximal LAD stenosis.
Provisional left main stenting was performed,...
DEB in peripheral intervention
19 May 2023 – From EuroPCR 2023
Want a refresher on the DEB's peripheral intervention session? Check out the slides here and deepen your understanding of the role, execution, and evaluation of results.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
